Penciclovir
5 NDCs across 4 manufacturers|4 Generic,1 Brand
Penciclovir is used to treat epstein-barr virus infections and herpes labialis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 24, 1996, and the first generic was approved Nov 9, 2022. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $4 million on Penciclovir across 6,399 claims for 4,061 beneficiaries.
Penciclovir is available as 5 NDCs from 4 manufacturers (4 generic, 1 brand), with NADAC prices from $52.15 to $155.08 per GM — the most expensive product costs about 3.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
4G / 1B
Manufacturers
4
competing in market
Price Spread
$52.15 – $155.08
per GM
7d Activity
avg +3.3% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Mylan Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing PENCICLOVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DENAVIR 1% CREAM | $155.0760 per GM | 0.00% |
PENCICLOVIR 1% CREAM | $52.1538 per GM | +4.13% |
PENCICLOVIR 1% CREAM | $52.1538 per GM | +4.13% |
PENCICLOVIR 1% CREAM | $52.1538 per GM | +4.13% |
PENCICLOVIR 1% CREAM | $52.1538 per GM | +4.13% |
Frequently Asked Questions
What is Penciclovir used to treat?
Penciclovir is used to treat epstein-barr virus infections and herpes labialis, per the National Library of Medicine's MED-RT classification.
When did Penciclovir become available as a generic?
FDA approved the first generic Penciclovir (ANDA) on Nov 9, 2022. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Penciclovir?
In 2024, Medicare Part D spent $4 million on Penciclovir across 6,399 claims for 4,061 beneficiaries.
How many Penciclovir products are on the market?
The Penciclovir drug market contains 5 NDCs from 4 manufacturers — 4 generic and 1 brand product.
What is the price range for Penciclovir?
NADAC reference prices for Penciclovir range from $52.1538 to $155.0760 per GM — the most expensive product costs about 3.0× the cheapest.
Is generic Penciclovir cheaper than brand?
The average generic NADAC for Penciclovir is $52.1538 per GM, versus $155.0760 for brand-labeled products — brand versions average about 3.0× the generic price.
Which manufacturers make Penciclovir?
4 manufacturers list Penciclovir in NADAC. Ranked by number of NDCs, the largest are Mylan Pharmaceuticals Inc. (2), Teva Pharmaceuticals USA Inc. (1), Torrent Pharmaceuticals Limited (1), Padagis Israel Pharmaceuticals Ltd (1).
How has the price of Penciclovir changed recently?
Over the past 7 days, 4 Penciclovir NDCs rose and 0 fell, with a market-wide average change of +3.3%.